These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35418787)

  • 1. The Necessity of Individualized Treatment for Sepsis-Associated Disseminated Intravascular Coagulation by Infected Organ.
    Kobayashi M; Ehama Y; Hirayama S
    Open Access Emerg Med; 2022; 14():133-140. PubMed ID: 35418787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Different Treatments for Disseminated Intravascular Coagulation on Patients with or without Biliary Drainage for Severe Biliary Tract Infection.
    Kobayashi M; Takai S; Sakurai K; Ehama Y
    Open Access Emerg Med; 2023; 15():437-445. PubMed ID: 38022742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Treatment of Perioperative Disseminated Intravascular Coagulation in Patients Who Underwent Gastrointestinal and Hepato-Biliary-Pancreatic Surgery.
    Tomioka K; Aoki T; Matsuda K; Enami Y; Fujimori A; Koizumi T; Kusano T; Date H; Yamashita T; Ariyoshi T; Goto S; Yamazaki K; Watanabe M; Otsuka K; Murakami M
    Am Surg; 2023 Apr; 89(4):907-913. PubMed ID: 34730467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
    Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
    Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
    World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study.
    Asai Y; Yamamoto T; Kito D; Ichikawa K; Abe Y
    J Pharm Health Care Sci; 2020 Dec; 6(1):26. PubMed ID: 33292809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
    Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
    Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
    Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
    Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
    Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
    Mitaka C; Kawagoe I; Satoh D; Hayashida M
    Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
    Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
    Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
    Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
    Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.
    Ito T; Nagahara A; Osada T; Kato J; Ueyama H; Saito H; Taniki N; Kanazawa R; Shimizu R; Sai J; Shiina S; Watanabe S
    Biomed Rep; 2015 Jul; 3(4):457-460. PubMed ID: 26171148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
    Totoki T; Makino Y; Yamakawa K; Koami H; Wada T; Ito T; Iba T
    Thromb J; 2024 Jan; 22(1):10. PubMed ID: 38225597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
    Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
    Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation Therapy Using rh-Thrombomodulin and/or Antithrombin III Agent is Associated With Reduction in in-Hospital Mortality in Septic Disseminated Intravascular Coagulation: A Nationwide Registry Study.
    Tanaka K; Takeba J; Matsumoto H; Ohshita M; Annen S; Moriyama N; Nakabayashi Y; Aibiki M
    Shock; 2019 Jun; 51(6):713-717. PubMed ID: 31090683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.